Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in Type II diabetes

Diabetologia

Volumn 43, Issue 6, 2000, Pages 703-708

  Gervaise, N ^a   Garrigue, M A ^a   Lasfargues, G ^a   Lecomte, P ^a  

^a CHU BRETONNEAU   (France)

Author keywords

Apolipoprotein C3; Cardiovascular risk; CHD; Lipoprotein B:C3; Macroangiopathy; Triglycerides; Type II diabetes

Indexed keywords

APOLIPOPROTEIN C3; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DIABETIC ANGIOPATHY; DISEASE DURATION; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034097892     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051366     Document Type: Article

References (34)

1. 1. Kannel WB, MacGee DL (1979) Diabetes and cardiovascular disease. The Framingham Study. JAMA 241: 2035-2038
2. 2. Kannel WB (1985) Lipids, diabetes, and coronary heart disease: Insights from the Framingham study. Am Heart J 110: 1100-1107
3. 3. Koskinen P, Mänttäri M, Manninen V, Huttunen J, Heinonen OP, Frick MH (1992) Coronary heart disease incidence in the Helsinki Heart Study. Diabetes Care 15: 820-825
4. 4. Ginsberg HN (1996) Diabetic dyslipidemia:basis mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes 45[Suppl 3]:S27-S31
5. 5. Ginsberg HN (1991) Lipoprotein physiology in non diabetic and diabetic states:relation to atherogenesis. Diabetes Care 14: 839-855
6. 6. Semenkovich CF, Heinecke JW (1997) The mystery of diabetes and atherosclerosis. Time for a new plot. Diabetes 46: 327-334
7. 7. Fontbonne A, Eschwège E, Cambien F et al. (1989) Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32: 300-304
8. 8. Puchois P, Alaupovic P, Fruchart JC (1985) Mise au point sur les classifications des lipoprotéines plasmatiques. Ann Biol Clin (Paris) 43: 831-840
9. 3 and E in apo B-and non apo B-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. J Lipid Res 37: 508-517
10. 10. Parra HJ, Arveiler D, Evans AE et al. (1992) A case-controlled study of lipoproteins particles in two populations at contrasting risk for coronary heart disease: the ECTIM study. Arterioscler Thromb 12: 701-707
11. 11. Rose G, MacCartney P, Reid DD (1977) Self administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 31: 42-48
12. 12. Bennett PH, Haffner S, Kasiske BL et al. (1995) Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations of the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 25:107-12
13. 13. Hosner DW, Lemeshow S (1989) Applied Logistic Regression. Wiley Series in Probability and Mathematical Statisics, John Wiley, New York
14. 3 genes by activating the nuclear receptor PPAR. Atherosclerosis 124[Suppl]:S29-S37
15. 15. Schoonjans K, Staels B, Auwerx J (1996) Role of the peroxysome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37: 907-925
16. 3 gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest 96: 2601-2605
17. 17. Ikeda T, Ohtani I, Fujiyama K et al. (1991) Apolipoproteins levels in non insulin dependent diabetes mellitus with clinical macroangiopathy. Diabetes Metab 17: 373-378
18. 18. Alaupovic P, Bard JM, Tavella M, Shafer D (1992) Identification of apo B-containing lipoprotein families in NIDDM. Diabetes 41[Suppl]:18-25
19. 19. Patti L, Swimburn B, Riccardi G, Rivellese AA, Howard BV (1991) Alterations in very low density lipoprotein subfractions in normotriglyceridaemic type 2 diabetes. Atherosclerosis 91: 15-23
20. 20. Hodis HN, Mack WJ, Azen SP et al. (1994) Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/ moderate and severe lesion progression as assessed by quantitative coronary angiography in a control trial of Lovastatin. Circulation 90: 42-49
21. 21. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP (1993) Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and non lipid factors. Circulation 88: 2762-2770
22. 22. Kreisberg RA (1998) Diabetic dyslipidemia. Am J Cardiol 82: 67U-73U
23. 23. Kraemer FB, Chen Y-DI, Lopez RD, Reaven GM (1985) effects of type 2 diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate elicited mouse peritoneal macrophages. J Clin Endocrinol Metab 61: 335-342
24. 24. Fredenrich A (1998) Role of apolipoprotein C3 in triglyceride rich lipoproteins metabolism. Diabetes Metab 24: 490-495
25. 25. Saïdi Y, Sich D, Camproux A, Egloff M, Federspiel MC et al. (1999) Interrelations between postprandial lipoprotein B/CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia. Metabolism 48: 60-67
26. 3 and reduced apo E on the particles. J Clin Invest 90: 1889-1900
27. 27. Windler E, Chao Y, Havel RJ (1980) Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoproteins E and individual C apoproteins. J Biol Chem 255: 8303-8307
28. 28. De Silva HV, Lauer SJ, Wang KH, Mahly RW, Taylor JM (1994) Overexpression of human apolipoprotein C III in transgenic mice. J Biol Chem 269: 2324-2335
29. 3 gene expression in transgenic mice. Science 249: 790-793
30. 3 inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 78: 1287-1295
31. 3 and E. Arterioscler Thromb Vasc Biol 15: 963-971
32. 32. Clavey V, Agnani G, Bard JM, Lestavel-Delattre S, Fruchart JC (1991) Interaction entre le LDL-récepteur et les lipoprotéines contenant de l'apo B. Ann Endocrinol (Paris) 52: 459-463
33. 3. J Clin Invest 75: 384-390
34. 34. Wingard DL, Barrett-Connor E, Criqui MH, Suarez L (1983) Clustering of heart disease risk factors in diabetic compared to non diabetic adults. Am J Epidemiol 117: 19-26